Author: Huang, Jie; Chen, Xinxin; Fu, Xuekun; Li, Zheng; Huang, Yuhong; Liang, Chao
Title: Advances in Aptamer-Based Biomarker Discovery Cord-id: cmo8w2de Document date: 2021_3_16
ID: cmo8w2de
Snippet: The discovery and identification of biomarkers promote the rational and fast development of medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is limited due to the suboptimal technology in biomarker discovery. Aptamers are single-stranded deoxyribonucleic acid or ribonucleic acid molecules and can selectively bind to varied targets with high affinity and specificity. Compared with antibody, aptamers have desirable advantages, such as flexible design, easy
Document: The discovery and identification of biomarkers promote the rational and fast development of medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is limited due to the suboptimal technology in biomarker discovery. Aptamers are single-stranded deoxyribonucleic acid or ribonucleic acid molecules and can selectively bind to varied targets with high affinity and specificity. Compared with antibody, aptamers have desirable advantages, such as flexible design, easy synthesis and convenient modification with different functional groups. Currently, different aptamer-based technologies have been developed to facilitate biomarker discovery, especially CELL-SELEX and SOMAScan technology. CELL-SELEX technology is mainly used to identify cell membrane surface biomarkers of various cells. SOMAScan technology is an unbiased biomarker detection method that can analyze numerous and even thousands of proteins in complex biological samples at the same time. It has now become a large-scale multi-protein biomarker discovery platform. In this review, we introduce the aptamer-based biomarker discovery technologies, and summarize and highlight the discovered emerging biomarkers recently in several diseases.
Search related documents:
Co phrase search for related documents- liver cancer and long term response: 1
- liver cancer and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- liver cancer and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- liver cancer and lymphoblastic leukemia: 1
- liver tissue and lung affect: 1
- liver tissue and lung cancer: 1, 2
- liver tissue and lung disease: 1, 2
- liver tissue and lung squamous: 1
- liver tissue and lung squamous cell carcinoma: 1
- living cell and lung disease: 1, 2
- local recurrence and long term response: 1
- local recurrence and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- local recurrence and lung disease: 1, 2
Co phrase search for related documents, hyperlinks ordered by date